J Musculoskelet Neuronal Interact, 2015 · DOI: · Published: January 15, 2015
Individuals with SCI are at increased risk of developing secondary complications, such as cardiovascular disease, type II diabetes, and osteoporosis, and often experience these conditions at an earlier age as compared to their able-bodied peers. Skeletal muscle plays a vital regulatory role in maintaining metabolic and bone health, and lower-extremity muscle atrophy is a major contributing factor to metabolic dysregulation after SCI5. The accumulation of adipose tissue within and between the muscle groups of the lower-extremities can be up to four times greater in those with SCI compared able-bodied controls
Modifiable factors related to muscle size, body composition, and activity level may offer therapeutic targets for preserving metabolic health after chronic SCI.
Body mass, motor-score, wheelchair use, spasticity, vigorous physical activity participation, age, and waist circumference can be clinical predictors of muscle status.
Maintaining muscle function, particularly through upright ambulation in individuals with incomplete SCI, may prevent muscle loss and secondary metabolic complications.